| |
| |
|
| Insider
Information: |
Dineen John M. |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
129,774 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,194,023 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
129,774 |
|
|
| Total
Value |
$3,194,023 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merrimack Pharmaceuticals Inc |
MACK |
Director |
2015-08-12 |
100,000 |
2015-08-12 |
0 |
Premium* |
|
|
Syneos Health Inc |
SYNH |
Director |
2023-05-25 |
27,492 |
2018-12-10 |
0 |
Premium* |
|
|
Lam Research Corp |
LRCX |
Director |
2023-11-10 |
455 |
2023-11-10 |
0 |
Premium* |
|
|
Cognizant Technology Solutions C... |
CTSH |
Director |
2023-11-13 |
1,827 |
2023-11-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTSH |
Cognizant Technology Solu... |
Director |
– • – |
2023-11-13 |
4 |
OE |
$59.52 |
$108,743 |
D/D |
1,827 |
1,827 |
0 |
- |
|
| LRCX |
Lam Research Corp |
Director |
– • – |
2023-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
455 |
455 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,863 |
27,492 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2022-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,839 |
22,629 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2021-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,364 |
19,790 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2020-07-06 |
4 |
AB |
$59.11 |
$513,725 |
D/D |
8,691 |
17,426 |
0 |
% |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2020-05-27 |
4 |
A |
$62.43 |
$174,991 |
D/D |
2,803 |
8,735 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2019-05-24 |
4 |
A |
$42.45 |
$174,979 |
D/D |
4,122 |
5,932 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2018-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,630 |
1,810 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2015-08-12 |
4 |
B |
$10.15 |
$1,015,000 |
D/D |
100,000 |
100,000 |
2.39 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
